3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting

Bruna A G de Melo1, Julia C Benincasa1, Elisa M Cruz1

  • 1Department of Biochemistry, Paulista School of Medicine, Universidade Federal de São Paulo, São Paulo, Brazil.

Biomedical Journal
|February 19, 2021
PubMed

Insights

Tissue engineering creates advanced 3D models for studying SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) and COVID-19. These models offer a more realistic in vitro platform for developing vaccines and antiviral therapies.

Area of Science:

  • Virology
  • Tissue Engineering
  • Biotechnology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has led to over a million deaths globally.
  • There is an urgent need for effective vaccines and antiviral drugs to combat the virus.
  • Conventional cell cultures have limitations in mimicking the complexity of human physiology during viral infections.

Purpose of the Study:

  • To review tissue engineering strategies for fabricating 3D models for virology research.
  • To highlight the advantages of 3D models over traditional cell cultures for studying viral infections.
  • To discuss the application of these models in developing COVID-19 vaccines and therapies.

Main Methods:

  • Review of scaffold-free methods (spheroids, organoids).
  • Review of scaffold-based methods (3D scaffolding, 3D bioprinting).
  • Fabrication of advanced 3D in vitro models.

Main Results:

  • 3D models offer complex cytoarchitecture and a more physiological microenvironment compared to 2D cultures.
  • Scaffold-free and scaffold-based approaches enable the creation of realistic models.
  • These models are suitable for studying viral infection mechanisms, replication, pathogenesis, and host-virus interactions.

Conclusions:

  • Tissue engineering provides powerful tools for developing advanced 3D models for virology.
  • These 3D models represent a significant advancement for in vitro research on SARS-CoV-2 and COVID-19.
  • Biofabricated 3D models are crucial for accelerating the development of novel vaccines and antiviral treatments.

Related Concept Videos